Pediatrix Medical Group, Inc. (MD)
(Delayed Data from NYSE)
$21.08 USD
+4.11 (24.22%)
Updated Nov 3, 2025 04:00 PM ET
After-Market: $21.04 -0.04 (-0.19%) 7:58 PM ET
1-Strong Buy of 5 1
A Value A Growth D Momentum A VGM
Key Expected Earnings Data
| Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP | 
|---|---|---|---|
| 02/19/2026
                            
                                
                             Time: --  | 
                            12/2025 | $0.46 | 0.00% | 
Earnings Summary
For their last quarter, Pediatrix Medical Group, Inc. (MD) reported earnings of $0.67 per share, beating the Zacks Consensus Estimate of $0.46 per share. This reflects a positive earnings surprise of 45.65%. Look out for MD's next earnings release expected on February 19, 2026. For the next earning release, we expect the company to report earnings of $0.46 per share, reflecting a year-over-year decrease of 9.8%.
Earnings History
Price & Consensus
Zacks News for MD
Here's Why Pediatrix Medical Group (MD) is a Strong Value Stock
MD: What are Zacks experts saying now?
Zacks Private Portfolio Services
MD or HQY: Which Is the Better Value Stock Right Now?
MD or HQY: Which Is the Better Value Stock Right Now?
MD FAQs
Based on past history, Zacks believes Pediatrix Medical Group, Inc. (MD) will report their next quarter earnings on February 18, 2025. For the next earning release, we expect the company to report earnings of 0.37 per share, reflecting a year-over-year increase of 15.63.
Based on past history, Zacks believes Pediatrix Medical Group, Inc. (MD) will report their previous quarter earnings %%TIME_OF_DAY_CODE%% on February 18, 2025.
The Zacks Consensus Estimate for Pediatrix Medical Group, Inc. (MD) for the quarter ending December 2024 is $0.37 a share. We expect Pediatrix Medical Group, Inc. (MD) to report earnings in line with the consensus estimate of $0.37 per share
In the earnings report for the quarter ending in September 2024, Pediatrix Medical Group, Inc. (MD) announced earnings of $0.44 per share versus the Zacks Consensus Estimate of $0.37 per share, representing a surprise of 18.92%.
    
    
    
